1. Home
  2. WERN vs CNTA Comparison

WERN vs CNTA Comparison

Compare WERN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WERN
  • CNTA
  • Stock Information
  • Founded
  • WERN 1956
  • CNTA 2020
  • Country
  • WERN United States
  • CNTA United Kingdom
  • Employees
  • WERN N/A
  • CNTA N/A
  • Industry
  • WERN Trucking Freight/Courier Services
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WERN Industrials
  • CNTA Health Care
  • Exchange
  • WERN Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • WERN 1.7B
  • CNTA 2.3B
  • IPO Year
  • WERN N/A
  • CNTA 2021
  • Fundamental
  • Price
  • WERN $27.63
  • CNTA $21.85
  • Analyst Decision
  • WERN Hold
  • CNTA Strong Buy
  • Analyst Count
  • WERN 13
  • CNTA 11
  • Target Price
  • WERN $31.08
  • CNTA $30.60
  • AVG Volume (30 Days)
  • WERN 574.0K
  • CNTA 1.5M
  • Earning Date
  • WERN 10-28-2025
  • CNTA 11-11-2025
  • Dividend Yield
  • WERN 2.02%
  • CNTA N/A
  • EPS Growth
  • WERN N/A
  • CNTA N/A
  • EPS
  • WERN 0.85
  • CNTA N/A
  • Revenue
  • WERN $2,965,642,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • WERN $1.11
  • CNTA N/A
  • Revenue Next Year
  • WERN $5.68
  • CNTA N/A
  • P/E Ratio
  • WERN $32.56
  • CNTA N/A
  • Revenue Growth
  • WERN N/A
  • CNTA 118.88
  • 52 Week Low
  • WERN $23.02
  • CNTA $9.60
  • 52 Week High
  • WERN $42.48
  • CNTA $23.24
  • Technical
  • Relative Strength Index (RSI)
  • WERN 44.61
  • CNTA 68.27
  • Support Level
  • WERN $27.27
  • CNTA $20.94
  • Resistance Level
  • WERN $28.78
  • CNTA $23.24
  • Average True Range (ATR)
  • WERN 0.78
  • CNTA 1.33
  • MACD
  • WERN -0.09
  • CNTA 0.41
  • Stochastic Oscillator
  • WERN 14.69
  • CNTA 83.11

About WERN Werner Enterprises Inc.

Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: